483
Matrix Pharmacorp Private LimitedFDA 483 - Matrix Pharmacorp Private Limited - September 01, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of MATRIX PHARMACORP PRIVATE LIMITED, UNIT 10, an API manufacturer in Anakapalli Dist., India, revealed significant deficiencies. The firm failed to adequately validate analytical methods, lacked sufficient controls over computerized systems leading to data integrity concerns, and had unscientific sampling procedures for API release testing. These issues indicate a systemic breakdown in quality control and data management practices.
Open in Dashboard
ID · 9c8ec5f8-fa51-48d0-8542-153ac22123c6